Yifan Pharmaceutical: the products under research by the holding subsidiary have obtained the Chinese drug registration certificate.

[Yifan Pharmaceutical: holding subsidiary obtains China Drug Registration Certificate for Research products] May 9, Yifan Pharmaceutical announced that the holding subsidiary obtained the Chinese Drug Registration Certificate in the research product Abergerstine α injection.